Predictive Oncology Inc. (NASDAQ:POAI) Short Interest Update

Predictive Oncology Inc. (NASDAQ:POAI) was the target of a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 395,800 shares, a decline of 22.7% from the February 28th total of 512,300 shares. Based on an average daily trading volume, of 4,350,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 5.6% of the shares of the stock are sold short.

Predictive Oncology Stock Performance

Shares of NASDAQ POAI traded down $0.02 during trading on Monday, reaching $1.43. The company had a trading volume of 137,159 shares, compared to its average volume of 2,326,113. Predictive Oncology has a 52 week low of $0.55 and a 52 week high of $3.06. The business’s 50 day moving average price is $1.37 and its 200-day moving average price is $1.02. The stock has a market cap of $9.76 million, a PE ratio of -0.48 and a beta of 1.22.

Predictive Oncology Company Profile

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.